Intarcia: Diabetes drug-device combo rejected again
Once hotly-tipped biotech Intarcia Therapeutics has been dealt a bodyblow from the US regulator, with...
Read full article »
Intarcia is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic diseases.
Read more